메뉴 건너뛰기




Volumn , Issue , 2007, Pages 197-212

Diabetes mellitus and magnesium

Author keywords

[No Author keywords available]

Indexed keywords


EID: 54049113648     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84628-483-0_16     Document Type: Chapter
Times cited : (9)

References (66)
  • 1
    • 0035856920 scopus 로고    scopus 로고
    • Global and societal implications of the diabetes epidemic
    • Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-787
    • (2001) Nature , vol.414 , pp. 782-787
    • Zimmet, P.1    Alberti, K.G.2    Shaw, J.3
  • 2
    • 0343068395 scopus 로고
    • Blood serum magnesium in portal cirrhosis and diabetes mellitus
    • Stutzman FL, Amatuzio DS. Blood serum magnesium in portal cirrhosis and diabetes mellitus. J Lab Clin Med 1953;41:215-219
    • (1953) J Lab Clin Med , vol.41 , pp. 215-219
    • Stutzman, F.L.1    Amatuzio, D.S.2
  • 3
    • 0018383486 scopus 로고
    • Magnesium status in diabetes
    • Mather HM, Levin GE. Magnesium status in diabetes. Lancet 1979;1:924
    • (1979) Lancet , vol.1 , pp. 924
    • Mather, H.M.1    Levin, G.E.2
  • 4
    • 0018225204 scopus 로고
    • Hypomagnesemia, a risk factor in diabetic retinopathy
    • McNair P, Christiansen C, Madsbad S, et al. Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes 1978;27:1075-1077
    • (1978) Diabetes , vol.27 , pp. 1075-1077
    • McNair, P.1    Christiansen, C.2    Madsbad, S.3
  • 6
    • 0020086353 scopus 로고
    • Magnesium levels of plasma, erythrocyte and urine in patients with diabetes mellitus
    • Fujii S, Takemura T, Wada M, Akai T, Okuda K. Magnesium levels of plasma, erythrocyte and urine in patients with diabetes mellitus. Horm Metab Res 1982; 14:161-162
    • (1982) Horm Metab Res , vol.14 , pp. 161-162
    • Fujii, S.1    Takemura, T.2    Wada, M.3    Akai, T.4    Okuda, K.5
  • 7
    • 0021666130 scopus 로고
    • Magnesium and potassium in diabetes and carbohydrate metabolism review of the present status and recent results
    • Durlach J, Collery P. Magnesium and potassium in diabetes and carbohydrate metabolism. Review of the present status and recent results. Magnesium 1984;3: 315-323
    • (1984) Magnesium , vol.3 , pp. 315-323
    • Durlach, J.1    Collery, P.2
  • 10
    • 0027321697 scopus 로고
    • Intracellular and extracellular magnesium depletion in type 2 (non-insulin-dependent) diabetes mellitus
    • Resnick LM, Altura BT, Gupta RK, Laragh JH, Alderman MH, Altura BM. Intracellular and extracellular magnesium depletion in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993;36:767-770
    • (1993) Diabetologia , vol.36 , pp. 767-770
    • Resnick, L.M.1    Altura, B.T.2    Gupta, R.K.3    Laragh, J.H.4    Alderman, M.H.5    Altura, B.M.6
  • 11
    • 3643099977 scopus 로고    scopus 로고
    • The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes
    • Lima Mde L, Cruz T, Pousada JC, Rodrigues LE, Barbosa K, Cangucu V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 1998;21:682-686
    • (1998) Diabetes Care , vol.21 , pp. 682-686
    • Lima Mde, L.1    Cruz, T.2    Pousada, J.C.3    Rodrigues, L.E.4    Barbosa, K.5    Cangucu, V.6
  • 12
    • 0024777685 scopus 로고
    • Determination of intracellular free magnesium by nuclear magnetic resonance in human magnesium deficiency
    • Ryzen E, Servis KL, DeRusso P, Kershaw A, Stephen T, Rude RK. Determination of intracellular free magnesium by nuclear magnetic resonance in human magnesium deficiency. J Am Coll Nutr 1989;8:580-587
    • (1989) J Am Coll Nutr , vol.8 , pp. 580-587
    • Ryzen, E.1    Servis, K.L.2    DeRusso, P.3    Kershaw, A.4    Stephen, T.5    Rude, R.K.6
  • 13
    • 19944424137 scopus 로고    scopus 로고
    • Complementary therapies for diabetes: The case for chromium, magnesium, and antioxidants
    • Guerrero-Romero F, Rodriguez-Moran M. Complementary therapies for diabetes: The case for chromium, magnesium, and antioxidants. Arch Med Res 2005;36: 250-257
    • (2005) Arch Med Res , vol.36 , pp. 250-257
    • Guerrero-Romero, F.1    Rodriguez-Moran, M.2
  • 14
    • 0021239766 scopus 로고
    • Fasting plasma magnesium concentrations and glucose disposal in diabetes
    • Yajnik CS, Smith RF, Hockaday TD, Ward NI. Fasting plasma magnesium concentrations and glucose disposal in diabetes. BMJ 1984;288:1032-1034
    • (1984) BMJ , vol.288 , pp. 1032-1034
    • Yajnik, C.S.1    Smith, R.F.2    Hockaday, T.D.3    Ward, N.I.4
  • 15
    • 2542489260 scopus 로고    scopus 로고
    • Role of cellular magnesium in health and human disease
    • Laires MJ, Monteiro CP, Bicho M. Role of cellular magnesium in health and human disease. Front Biosci 2004;9:262-276
    • (2004) Front Biosci , vol.9 , pp. 262-276
    • Laires, M.J.1    Monteiro, C.P.2    Bicho, M.3
  • 16
    • 0030936915 scopus 로고    scopus 로고
    • Hypertension, diabetes mellitus, and insulin resistance: The role of intracellular magnesium
    • Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: The role of intracellular magnesium. Am J Hypertens 1997;10:346-355
    • (1997) Am J Hypertens , vol.10 , pp. 346-355
    • Paolisso, G.1    Barbagallo, M.2
  • 18
    • 0036076622 scopus 로고    scopus 로고
    • Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the framingham offspring study
    • McKeown NM, Meigs JB, Liu S, Wilson PW, Jacques PF. Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr 2002;76:390-398
    • (2002) Am J Clin Nutr , vol.76 , pp. 390-398
    • McKeown, N.M.1    Meigs, J.B.2    Liu, S.3    Wilson, P.W.4    Jacques, P.F.5
  • 19
    • 0041333811 scopus 로고    scopus 로고
    • Dietary magnesium intake and the future risk of coronary heart disease (the honolulu heart program
    • Abbott RD, Ando F, Masaki KH, et al. Dietary magnesium intake and the future risk of coronary heart disease (the Honolulu Heart Program). Am J Cardiol 2003; 92:665-669
    • (2003) Am J Cardiol , vol.92 , pp. 665-669
    • Abbott, R.D.1    Ando, F.2    Masaki, K.H.3
  • 20
    • 1042268737 scopus 로고    scopus 로고
    • Magnesium intake and risk of type 2 diabetes in men and women
    • Lopez-Ridaura R, Willett WC, Rimm EB, et al. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 2004;27:134-140
    • (2004) Diabetes Care , vol.27 , pp. 134-140
    • Lopez-Ridaura, R.1    Willett, W.C.2    Rimm, E.B.3
  • 21
    • 1042268741 scopus 로고    scopus 로고
    • Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women
    • Song Y, Manson JE, Buring JE, Liu S. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 2004;27: 59-65
    • (2004) Diabetes Care , vol.27 , pp. 59-65
    • Song, Y.1    Manson, J.E.2    Buring, J.E.3    Liu, S.4
  • 22
    • 0024232088 scopus 로고
    • Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus
    • Sjogren A, Floren CH, Nilsson A. Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus. Acta Med Scand 1988;224:461-466
    • (1988) Acta Med Scand , vol.224 , pp. 461-466
    • Sjogren, A.1    Floren, C.H.2    Nilsson, A.3
  • 23
    • 0031884560 scopus 로고    scopus 로고
    • Intracellular magnesium depletion relates to increased urinary magnesium loss in type I diabetes
    • Gurlek A, Bayraktar M, Ozaltin N. Intracellular magnesium depletion relates to increased urinary magnesium loss in type I diabetes. Horm Metab Res 1998;30:99-102
    • (1998) Horm Metab Res , vol.30 , pp. 99-102
    • Gurlek, A.1    Bayraktar, M.2    Ozaltin, N.3
  • 24
    • 0022450297 scopus 로고
    • Magnesium deficiency in IDDM related to level of glycosylated hemoglobin
    • Sjogren A, Floren CH, Nilsson A. Magnesium deficiency in IDDM related to level of glycosylated hemoglobin. Diabetes 1986;35:459-463
    • (1986) Diabetes , vol.35 , pp. 459-463
    • Sjogren, A.1    Floren, C.H.2    Nilsson, A.3
  • 25
    • 0024432270 scopus 로고
    • Subclinical hyponatremia, hyperkalemia and hypomagnesemia in patients with poorly controlled diabetes mellitus
    • Pun KK, Ho PW. Subclinical hyponatremia, hyperkalemia and hypomagnesemia in patients with poorly controlled diabetes mellitus. Diabetes Res Clin Pract 1989;7: 163-167
    • (1989) Diabetes Res Clin Pract , vol.7 , pp. 163-167
    • Pun, K.K.1    Ho, P.W.2
  • 26
    • 0029072419 scopus 로고
    • Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The aric study atherosclerosis risk in communities study
    • Ma J, Folsom AR, Melnick SL, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1995;48:927-940
    • (1995) J Clin Epidemiol , vol.48 , pp. 927-940
    • Ma, J.1    Folsom, A.R.2    Melnick, S.L.3
  • 27
    • 0026601697 scopus 로고
    • Hypomagnesaemia in type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-Term metabolic control
    • Schnack C, Bauer I, Pregant P, Hopmeier P, Schernthaner G. Hypomagnesaemia in type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-Term metabolic control. Diabetologia 1992;35:77-79
    • (1992) Diabetologia , vol.35 , pp. 77-79
    • Schnack, C.1    Bauer, I.2    Pregant, P.3    Hopmeier, P.4    Schernthaner, G.5
  • 28
    • 0033030444 scopus 로고    scopus 로고
    • Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes
    • Djurhuus MS, Henriksen JE, Klitgaard NA, et al. Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes. Diabetes Care 1999;22:546-554
    • (1999) Diabetes Care , vol.22 , pp. 546-554
    • Djurhuus, M.S.1    Henriksen, J.E.2    Klitgaard, N.A.3
  • 29
    • 10844222546 scopus 로고    scopus 로고
    • Measurement of magnesium absorption and retention in type 2 diabetic patients with the use of stable isotopes
    • Walti MK, Zimmermann MB, Walczyk T, Spinas GA, Hurrell RF. Measurement of magnesium absorption and retention in type 2 diabetic patients with the use of stable isotopes. Am J Clin Nutr 2003;78:448-453
    • (2003) Am J Clin Nutr , vol.78 , pp. 448-453
    • Walti, M.K.1    Zimmermann, M.B.2    Walczyk, T.3    Spinas, G.A.4    Hurrell, R.F.5
  • 31
    • 23844544155 scopus 로고    scopus 로고
    • Further evidence for the regulation of acetyl-CoA carboxylase activity by a glutamate-And magnesiumactivated protein phosphatase in the pancreatic beta cell: Defective regulation in the diabetic GK rat islet
    • Palanivel R, Veluthakal R, McDonald P, Kowluru A. Further evidence for the regulation of acetyl-CoA carboxylase activity by a glutamate-And magnesiumactivated protein phosphatase in the pancreatic beta cell: Defective regulation in the diabetic GK rat islet. Endocrine 2005;26:71-77
    • (2005) Endocrine , vol.26 , pp. 71-77
    • Palanivel, R.1    Veluthakal, R.2    McDonald, P.3    Kowluru, A.4
  • 32
    • 0021916198 scopus 로고
    • Serum magnesium in insulin-dependent diabetics and healthy subjects in relation to insulin secretion and glycemia during glucose-glucagon test
    • Menzel R, Pusch H, Ratzmann GW, et al. Serum magnesium in insulin-dependent diabetics and healthy subjects in relation to insulin secretion and glycemia during glucose-glucagon test. Exp Clin Endocrinol 1985;85:81-88
    • (1985) Exp Clin Endocrinol , vol.85 , pp. 81-88
    • Menzel, R.1    Pusch, H.2    Ratzmann, G.W.3
  • 33
    • 0024402335 scopus 로고
    • Dietary magnesium supplements improve B-cell response to glucose and arginine in elderly non-insulin dependent diabetic subjects
    • Paolisso G, Passariello N, Pizza G, et al. Dietary magnesium supplements improve B-cell response to glucose and arginine in elderly non-insulin dependent diabetic subjects. Acta Endocrinol 1989;121:16-20
    • (1989) Acta Endocrinol , vol.121 , pp. 16-20
    • Paolisso, G.1    Passariello, N.2    Pizza, G.3
  • 35
    • 0026653825 scopus 로고
    • Daily magnesium supplements improve glucose handling in elderly subjects
    • Paolisso G, Sgambato S, Gambardella A, et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr 1992;55:1161-1167
    • (1992) Am J Clin Nutr , vol.55 , pp. 1161-1167
    • Paolisso, G.1    Sgambato, S.2    Gambardella, A.3
  • 37
    • 0029895208 scopus 로고    scopus 로고
    • Magnesium deficiency and glucose metabolism in rat adipocytes
    • Kandeel FR, Balon E, Scott S, Nadler JL. Magnesium deficiency and glucose metabolism in rat adipocytes. Metabolism 1996;45:838-843
    • (1996) Metabolism , vol.45 , pp. 838-843
    • Kandeel, F.R.1    Balon, E.2    Scott, S.3    Nadler, J.L.4
  • 38
    • 0028862204 scopus 로고
    • Impaired tyrosinekinase activity of muscle insulin receptors from hypomagnesaemic rats
    • Suarez A, Pulido N, Casla A, Casanova B, Arrieta FJ, Rovira A. Impaired tyrosinekinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia 1995;38:1262-1270
    • (1995) Diabetologia , vol.38 , pp. 1262-1270
    • Suarez, A.1    Pulido, N.2    Casla, A.3    Casanova, B.4    Arrieta, F.J.5    Rovira, A.6
  • 40
    • 0028874537 scopus 로고
    • Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM
    • Balon TW, Gu JL, Tokuyama Y, Jasman AP, Nadler JL. Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am J Physiol 1995;269:E745-E752
    • (1995) Am J Physiol , vol.269
    • Balon, T.W.1    Gu, J.L.2    Tokuyama, Y.3    Jasman, A.P.4    Nadler, J.L.5
  • 41
    • 4243066297 scopus 로고    scopus 로고
    • Intracellular magnesium and insulin resistance
    • Takaya J, Higashino H, Kobayashi Y. Intracellular magnesium and insulin resistance. Magnes Res 2004;17:126-136
    • (2004) Magnes Res , vol.17 , pp. 126-136
    • Takaya, J.1    Higashino, H.2    Kobayashi, Y.3
  • 43
    • 0037326196 scopus 로고    scopus 로고
    • Peroxisome proliferator-Activated receptor-gamma coactivator 1 alpha (pgc-1 alpha): Transcriptional coactivator and metabolic regulator
    • Puigserver P, Spiegelman BM. Peroxisome proliferator-Activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): Transcriptional coactivator and metabolic regulator. Endocr Rev 2003;24:78-90
    • (2003) Endocr Rev , vol.24 , pp. 78-90
    • Puigserver, P.1    Spiegelman, B.M.2
  • 44
    • 0037398675 scopus 로고    scopus 로고
    • Pioglitazone increases serum magnesium levels in glucose-intolerant subjects a randomized, controlled trial
    • Guerrero-Romero F, Rodriguez-Moran M. Pioglitazone increases serum magnesium levels in glucose-intolerant subjects. A randomized, controlled trial. Exp Clin Endocrinol Diabetes 2003;111:91-96
    • (2003) Exp Clin Endocrinol Diabetes , vol.111 , pp. 91-96
    • Guerrero-Romero, F.1    Rodriguez-Moran, M.2
  • 45
    • 0021813187 scopus 로고
    • Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
    • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-419
    • (1985) Diabetologia , vol.28 , pp. 412-419
    • Matthews, D.R.1    Hosker, J.P.2    Rudenski, A.S.3    Naylor, B.A.4    Treacher, D.F.5    Turner, R.C.6
  • 46
    • 0032896330 scopus 로고    scopus 로고
    • Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas
    • Emoto M, Nishizawa Y, Maekawa K, et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999;22:818-822
    • (1999) Diabetes Care , vol.22 , pp. 818-822
    • Emoto, M.1    Nishizawa, Y.2    Maekawa, K.3
  • 47
    • 0034456568 scopus 로고    scopus 로고
    • Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans
    • Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410
    • (2000) J Clin Endocrinol Metab , vol.85 , pp. 2402-2410
    • Katz, A.1    Nambi, S.S.2    Mather, K.3
  • 48
    • 12144290252 scopus 로고    scopus 로고
    • Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose
    • Yokoyama H, Emoto M, Fujiwara S, et al. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose. J Clin Endocrinol Metab 2004;89:1481-1484
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 1481-1484
    • Yokoyama, H.1    Emoto, M.2    Fujiwara, S.3
  • 49
    • 18144423955 scopus 로고    scopus 로고
    • Magnesium deficiency is associated with insulin resistance in obese children
    • Huerta MG, Roemmich JN, Kington ML, et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care 2005;28:1175-1181
    • (2005) Diabetes Care , vol.28 , pp. 1175-1181
    • Huerta, M.G.1    Roemmich, J.N.2    Kington, M.L.3
  • 50
    • 0028934616 scopus 로고
    • Effects of insulin on plasma magnesium in noninsulin-dependent diabetes mellitus: Evidence for insulin resistance
    • Alzaid AA, Dinneen SF, Moyer TP, Rizza RA. Effects of insulin on plasma magnesium in noninsulin-dependent diabetes mellitus: Evidence for insulin resistance. J Clin Endocrinol Metab 1995;80:1376-1381
    • (1995) J Clin Endocrinol Metab , vol.80 , pp. 1376-1381
    • Alzaid, A.A.1    Dinneen, S.F.2    Moyer, T.P.3    Rizza, R.A.4
  • 51
    • 0032869614 scopus 로고    scopus 로고
    • Low dietary magnesium is associated with insulin resistance in a sample of young, nondiabetic black americans
    • Humphries S, Kushner H, Falkner B. Low dietary magnesium is associated with insulin resistance in a sample of young, nondiabetic Black Americans. Am J Hypertens 1999;12:747-756
    • (1999) Am J Hypertens , vol.12 , pp. 747-756
    • Humphries, S.1    Kushner, H.2    Falkner, B.3
  • 53
    • 0030702902 scopus 로고    scopus 로고
    • Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects
    • Rosolova H, Mayer O Jr, Reaven G. Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects. J Clin Endocrinol Metab 1997;82:3783-3785
    • (1997) J Clin Endocrinol Metab , vol.82 , pp. 3783-3785
    • Rosolova, H.1    Mayer Jr., O.2    Reaven, G.3
  • 54
    • 0034064791 scopus 로고    scopus 로고
    • Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations
    • Rosolova H, Mayer O Jr, Reaven GM. Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations. Metabolism 2000;49:418-420
    • (2000) Metabolism , vol.49 , pp. 418-420
    • Rosolova, H.1    Mayer Jr., O.2    Reaven, G.M.3
  • 56
    • 0036721480 scopus 로고    scopus 로고
    • Whole-grain intake and the risk of type 2 diabetes: A prospective study in men
    • Fung TT, Hu FB, Pereira MA, et al. Whole-grain intake and the risk of type 2 diabetes: A prospective study in men. Am J Clin Nutr 2002;76:535-540
    • (2002) Am J Clin Nutr , vol.76 , pp. 535-540
    • Fung, T.T.1    Hu, F.B.2    Pereira, M.A.3
  • 57
    • 0037184499 scopus 로고    scopus 로고
    • Nut and peanut butter consumption and risk of type 2 diabetes in women
    • Jiang R, Manson JE, Stampfer MJ, Liu S, Willett WC, Hu FB. Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA 2002;288:2554-2560
    • (2002) JAMA , vol.288 , pp. 2554-2560
    • Jiang, R.1    Manson, J.E.2    Stampfer, M.J.3    Liu, S.4    Willett, W.C.5    Hu, F.B.6
  • 58
    • 0033547207 scopus 로고    scopus 로고
    • Serum and dietary magnesium and the risk for type 2 diabetes mellitus: The atherosclerosis risk in communities study
    • Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: The Atherosclerosis Risk in Communities Study. Arch Intern Med 1999;159:2151-2159
    • (1999) Arch Intern Med , vol.159 , pp. 2151-2159
    • Kao, W.H.1    Folsom, A.R.2    Nieto, F.J.3    Mo, J.P.4    Watson, R.L.5    Brancati, F.L.6
  • 59
    • 0028227194 scopus 로고
    • Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients
    • Paolisso G, Scheen A, Cozzolino D, et al. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab 1994;78:1510-1514
    • (1994) J Clin Endocrinol Metab , vol.78 , pp. 1510-1514
    • Paolisso, G.1    Scheen, A.2    Cozzolino, D.3
  • 60
    • 0041666626 scopus 로고    scopus 로고
    • Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: A randomized double-blind controlled trial
    • Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: A randomized double-blind controlled trial. Diabetes Care 2003;26:1147-1152
    • (2003) Diabetes Care , vol.26 , pp. 1147-1152
    • Rodriguez-Moran, M.1    Guerrero-Romero, F.2
  • 61
    • 16644365360 scopus 로고    scopus 로고
    • Clinical Efficacy of magnesium supplementation in patients with type 2 diabetes
    • Yokota K, Kato M, Lister F, et al. Clinical Efficacy of magnesium supplementation in patients with type 2 diabetes. J Am Coll Nutr 2004;23:506S-509S
    • (2004) J Am Coll Nutr , vol.23
    • Yokota, K.1    Kato, M.2    Lister, F.3
  • 62
    • 0028297080 scopus 로고
    • Effect of magnesium treatment on glycemic control and metabolic parameters in niddm patients
    • Gullestad L, Jacobsen T, Dolva LO. Effect of magnesium treatment on glycemic control and metabolic parameters in NIDDM patients. Diabetes Care 1994;17:460-461
    • (1994) Diabetes Care , vol.17 , pp. 460-461
    • Gullestad, L.1    Jacobsen, T.2    Dolva, L.O.3
  • 65
    • 3142708531 scopus 로고    scopus 로고
    • Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance A double-blind placebo-controlled randomized trial
    • Guerrero-Romero F, Tamez-Perez HE, Gonzalez-Gonzalez G, et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab 2004;30:253-258
    • (2004) Diabetes Metab , vol.30 , pp. 253-258
    • Guerrero-Romero, F.1    Tamez-Perez, H.E.2    Gonzalez-Gonzalez, G.3
  • 66
    • 1042280180 scopus 로고    scopus 로고
    • A new dietary approach to reduce the risk of type 2 diabetes
    • Nadler JL. A new dietary approach to reduce the risk of type 2 diabetes? Diabetes Care 2004;27:270-271.
    • (2004) Diabetes Care , vol.27 , pp. 270-271
    • Nadler, J.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.